New pancreatic cancer drug hailed ‘closest thing to a cure’ after clinical trial
Daraxonrasib made headlines in May after it was found to almost double survival time for patients when compared to chemotherapy alone
How the newspaper covers this story
New pancreatic cancer drug hailed ‘closest thing to a cure’ after clinical trial
Daraxonrasib made headlines in May after it was found to almost double survival time for patients when compared to chemotherapy alone

